SPHDF
Price
$14.75
Change
-$1.15 (-7.23%)
Updated
May 28 closing price
Capitalization
230.61M
TRML
Price
$19.77
Change
+$1.02 (+5.44%)
Updated
Jul 25 closing price
Capitalization
507.86M
Interact to see
Advertisement

SPHDF vs TRML

Header iconSPHDF vs TRML Comparison
Open Charts SPHDF vs TRMLBanner chart's image
Santhera Pharmaceuticals Holdings
Price$14.75
Change-$1.15 (-7.23%)
Volume$285
Capitalization230.61M
Tourmaline Bio
Price$19.77
Change+$1.02 (+5.44%)
Volume$246.52K
Capitalization507.86M
SPHDF vs TRML Comparison Chart in %
Loading...
SPHDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SPHDF vs. TRML commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SPHDF is a Hold and TRML is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (SPHDF: $14.75 vs. TRML: $19.77)
Brand notoriety: SPHDF and TRML are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SPHDF: 105% vs. TRML: 111%
Market capitalization -- SPHDF: $230.61M vs. TRML: $507.86M
SPHDF [@Biotechnology] is valued at $230.61M. TRML’s [@Biotechnology] market capitalization is $507.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SPHDF’s FA Score shows that 1 FA rating(s) are green whileTRML’s FA Score has 1 green FA rating(s).

  • SPHDF’s FA Score: 1 green, 4 red.
  • TRML’s FA Score: 1 green, 4 red.
According to our system of comparison, SPHDF is a better buy in the long-term than TRML.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SPHDF’s TA Score shows that 0 TA indicator(s) are bullish while TRML’s TA Score has 5 bullish TA indicator(s).

  • SPHDF’s TA Score: 0 bullish, 1 bearish.
  • TRML’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, TRML is a better buy in the short-term than SPHDF.

Price Growth

SPHDF (@Biotechnology) experienced а 0.00% price change this week, while TRML (@Biotechnology) price change was +6.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

TRML is expected to report earnings on May 02, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRML($508M) has a higher market cap than SPHDF($231M). SPHDF YTD gains are higher at: 56.582 vs. TRML (-2.515).
SPHDFTRMLSPHDF / TRML
Capitalization231M508M45%
EBITDAN/A-98.41M-
Gain YTD56.582-2.515-2,250%
P/E Ratio2.53N/A-
RevenueN/A0-
Total CashN/A249M-
Total DebtN/A196K-
FUNDAMENTALS RATINGS
SPHDF: Fundamental Ratings
SPHDF
OUTLOOK RATING
1..100
42
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
12
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SPHDFTRML
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
77%
Stochastic
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
86%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
73%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
11%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
12%
Bullish Trend 1 day ago
88%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
N/A
Bearish Trend 6 days ago
88%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
55%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
SPHDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
UPAAX15.51N/A
N/A
Upright Assets Allocation Plus
VWICX15.76N/A
N/A
Vanguard International Core Stock Inv
FAOAX37.65N/A
N/A
Fidelity Advisor Overseas A
EVSRX26.18N/A
N/A
Allspring Disciplined US Core R6
DRECX41.43-0.07
-0.17%
Davis Real Estate C

SPHDF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPHDF has been closely correlated with TRML. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if SPHDF jumps, then TRML could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPHDF
1D Price
Change %
SPHDF100%
N/A
TRML - SPHDF
78%
Closely correlated
+5.44%
COGT - SPHDF
63%
Loosely correlated
-0.98%
MEOBF - SPHDF
50%
Loosely correlated
N/A
KROS - SPHDF
38%
Loosely correlated
+0.56%
CYTOF - SPHDF
35%
Loosely correlated
+5.90%
More

TRML and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRML has been closely correlated with SPHDF. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if TRML jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRML
1D Price
Change %
TRML100%
+5.44%
SPHDF - TRML
78%
Closely correlated
N/A
STOK - TRML
48%
Loosely correlated
-3.03%
IMNM - TRML
47%
Loosely correlated
-3.29%
SYRE - TRML
45%
Loosely correlated
+1.08%
IDYA - TRML
44%
Loosely correlated
-1.33%
More